Taiwan Union Technology (6274) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
1 Jul, 2026Executive summary
Net revenue reached NT$6,622 million in 3Q24, up 16.1% sequentially and 58.5% year-over-year.
Net income rose to NT$754 million in 3Q24, an 8.7% increase from 2Q24 and more than double 3Q23.
EPS improved to NT$2.77 in 3Q24, up 8.6% from the previous quarter and 104.2% year-over-year.
Revenue for the nine months ended September 30, 2024, was NT$16.76 billion, up 45% year-over-year, with net profit reaching NT$1.90 billion.
Gross margin improved to 23% from 19% year-over-year, reflecting higher sales and better cost control.
Financial highlights
Gross margin was 22.7% in 3Q24, down 1.2 points sequentially but up 2.6 points year-over-year.
Operating margin stood at 14.6% in 3Q24, a 0.5 point decrease from 2Q24 but a 4.8 point increase from 3Q23.
Net profit margin was 11.4% in 3Q24, down 0.8 points sequentially but up 2.5 points year-over-year.
Operating profit for the nine months was NT$2.40 billion, up from NT$905 million year-over-year.
Total assets as of September 30, 2024, were NT$24.86 billion, up from NT$19.12 billion a year earlier.
Segment performance
HSD-Low Loss (HSD-L) technology contributed 63% of CCL revenue in 3Q24, up from 62% in 2Q24 and 54% in 3Q23.
HSD-Non Low Loss (HSD-NL) accounted for 22% of CCL revenue, while HDI and Others made up 5% and 10%, respectively.
Domestic sales and manufacturing contributed NT$6.67 billion in revenue and NT$502 million in segment profit for the nine months.
Overseas sales and manufacturing generated NT$10.09 billion in revenue and NT$1.90 billion in segment profit.
Latest events from Taiwan Union Technology
- Net income and revenue surged year-over-year, driven by margin gains and a shift to advanced technologies.6274
Q2 202629 Jul 2026 - Net profit up 216% YoY to NT$2.60 billion, EPS at NT$9.56, HSD-Low Loss tech at 66% of CCL revenue.6274
Q4 20241 Jul 2026 - Revenue and profit grew year-over-year, but margins and cash balances declined.6274
Q2 20251 Jul 2026 - Revenue and profit surged on strong overseas sales and HSD-Low Loss technology, despite negative free cash flow.6274
Q3 20251 Jul 2026 - Net income rebounded in Q1 2024 on strong revenue and margin gains, led by HSD-Low Loss growth.6274
Q1 20241 Jul 2026 - Strong revenue and profit growth, led by HSD-Low Loss technology and new bond issuance.6274
Q2 20241 Jul 2026 - Revenue up 44% and net profit up 49% year-over-year, with HSD-Low Loss products leading growth.6274
Q1 20251 Jul 2026 - Revenue and profit surged over 30% year-over-year, led by ELL & SLL and VLL & LL segments.6274
Q4 202530 Jun 2026 - Strong revenue and profit growth in Q1 2026, led by ELL & SLL, despite negative free cash flow.6274
Q1 202630 Jun 2026